| Literature DB >> 33768985 |
Abstract
BACKGROUND: This study aims to examine preoperative white blood cell count and lymphocyte/monocyte ratio and to investigate foreknown risk factors for pneumonia following lobectomy.Entities:
Keywords: Lung cancer; lymphocyte; monocyte; pneumonia; postoperative complications
Year: 2021 PMID: 33768985 PMCID: PMC7970090 DOI: 10.5606/tgkdc.dergisi.2021.19950
Source DB: PubMed Journal: Turk Gogus Kalp Damar Cerrahisi Derg ISSN: 1301-5680 Impact factor: 0.332
Demographic and clinical characteristics of patients
| Variables | n | % | Mean±SD | Min-Max |
| Sex | ||||
| Female | 17 | 11.2 | ||
| Male | 135 | 88.8 | ||
| Postoperative pneumonia | ||||
| None | 127 | 83.6 | ||
| Present | 25 | 16.4 | ||
| Smoking | ||||
| None | 113 | 74.3 | ||
| Active | 39 | 25.7 | ||
| Chronic disease | ||||
| None | 90 | 59.2 | ||
| Diabetes mellitus | 20 | 13.2 | ||
| Chronic obstructive pulmonary disease | 19 | 12.5 | ||
| Cardiovascular disease | 23 | 15.1 | ||
| Body mass index (kg/m2) | ||||
| <30 | 102 | 67.1 | ||
| ≥30 | 50 | 32.9 | ||
| Stage of lung cancer | ||||
| Ia | 32 | 21.1 | ||
| Ib | 49 | 32.2 | ||
| IIa | 35 | 23.0 | ||
| IIb | 28 | 18.4 | ||
| IIIa | 8 | 5.3 | ||
| Neoadjuvant chemotherapy | ||||
| None | 117 | 77.0 | ||
| Present | 35 | 23.0 | ||
| Surgery | ||||
| Thoracotomy | 105 | 69.1 | ||
| VATS | 47 | 30.9 | ||
| Blood transfusion | ||||
| None | 120 | 78.9 | ||
| Present | 32 | 21.1 | ||
| Postoperative ICU admission | ||||
| None | 135 | 88.8 | ||
| Present | 17 | 11.2 | ||
| Age (year) | 61.9±7.5 | 45-73 | ||
| Preoperative WBC (/µL) | 7,476.3±1,382.3 | 4,950-10,800 | ||
| Preoperative LMR | 1.3±0.5 | 0.5-3.1 | ||
| Smoking (pack year) | 12.5±7.7 | 0-40 | ||
| Operative time (min) | 92.8±17.7 | 60-160 | ||
| SD: Standard deviation; Min: Minimum; Max: Maximum; VATS: Video-assisted thoracic surgery; ICU: Intensive care unit; WBC: White blood cell count; LMR: Lymphocyte/monocyte ratio. | ||||
Comparison of patients regarding the development of postoperative pneumonia
| Postoperative pneumonia | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| None | Present | ||||||||
| Variables | n | % | Mean±SD | Min-Max | n | % | Mean±SD | Min-Max | |
| Sex | 0.212* | ||||||||
| Female | 16 | 12.6 | 1 | 4.0 | |||||
| Male | 111 | 87.4 | 24 | 96.0 | |||||
| Smoking | 0.001* | ||||||||
| None | 111 | 87.4 | 2 | 8.0 | |||||
| Active | 16 | 12.6 | 23 | 92.0 | |||||
| Chronic disease | 0.001* | ||||||||
| None | 89 | 70.1 | 1 | 4.0 | |||||
| DM | 9 | 7.1 | 11 | 44.0 | |||||
| COPD | 12 | 9.4 | 7 | 28.0 | |||||
| CVD | 17 | 13.4 | 6 | 24.0 | |||||
| BMI (kg/m2) | 0.001* | ||||||||
| <30 | 97 | 76.4 | 5 | 20.0 | |||||
| >30 | 30 | 23.6 | 20 | 80.0 | |||||
| Stage of lung cancer | 0.001* | ||||||||
| Ia | 32 | 25.2 | 0 | 0 | |||||
| Ib | 49 | 38.6 | 0 | 0 | |||||
| IIa | 31 | 24.4 | 4 | 16.0 | |||||
| IIb | 12 | 9.4 | 16 | 64.0 | |||||
| IIIa | 3 | 2.4 | 5 | 20.0 | |||||
| Neoadjuvant chemotherapy | 0.001* | ||||||||
| None | 112 | 88.2 | 5 | 20.0 | |||||
| Present | 15 | 11.8 | 20 | 80.0 | |||||
| Surgery | 0.730* | ||||||||
| Thoracotomy | 87 | 68.5 | 18 | 72.0 | |||||
| VATS | 40 | 31.5 | 7 | 28.0 | |||||
| Blood transfusion | 0.888* | ||||||||
| None | 100 | 78.7 | 5 | 61.5 | |||||
| Present | 27 | 21.3 | 8 | 38.5 | |||||
| Postoperative ICU admission | 0.001* | ||||||||
| None | 127 | 100 | 8 | 32.0 | |||||
| Present | 0 | 0 | 17 | 68.0 | |||||
| SD: Standard deviation; Min: Minimum; Max: Maximum; DM: Diabetes mellitus; COPD: Chronic obstructive pulmonary disease; CVD: Cardiovascular disease; BMI: Body mass index; VATS: Video-assisted thoracic surgery; ICU: Intensive care unit; WBC: White blood cell count; LMR: Lymphocyte/monocyte rate; * Chi-square test; ** Independent T- test. | |||||||||
Figure 2ROC curve of WBC and LMR in predicting post-lobectomy pneumonia.
ROC: Receiver operating characteristics; LMR: Lymphocyte/monocyte rate; WBC: White blood cell count.